Improving Testing Protocol for Inhibitors in Hemophilia 1077 Rachna Chandora, MPH Chronic Disease & Birth Defects Birth Defects Image Off CDC's National Center on Birth Defects and Developmental Disabilities Genentech, Inc. United States of America /give To determine whether inhibitor testing can be more efficiently, cost-effectively, and accurately executed. Hemophilia